RecruitingNot ApplicableNCT06460805

axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in Axial Spondyloarthritis

axSEND: Exploring Immune and Microbiota Effects of a Partial Enteral Nutrition Diet in People With Axial Spondyloarthritis


Sponsor

NHS Greater Glasgow and Clyde

Enrollment

62 participants

Start Date

Apr 25, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

People with axial spondyloarthritis (axSpA) often have intestinal inflammation and intestinal microbiome dysbiosis, with some similarities to Crohn's-like inflammatory bowel disease (IBD) gut inflammation. However, research has not addressed whether Partial Enteral Nutrition (PEN), a diet formed of a liquid formula and some solid whole foods, which is effective at inducing remission in IBD, may influence the dysbiotic microbiome and inflamed, hyperpermeable intestine of axSpA patients, and whether these changes may be accompanied by alterations in systemic markers of inflammation. Thus, there is a need to determine the effects of PEN on these aspects in axSpA patients. In this study, the investigators intend to trial a 2-week course (with optional additional 2-week extension) of a PEN diet in people with active axSpA disease. A group of healthy volunteers following the same diet will act as a control.


Eligibility

Min Age: 16 Years

Inclusion Criteria32

  • Eligibility Criteria for Participants with axSpA
  • Diagnosis of axSpA (fulfilling the ASAS criteria)
  • Active disease (BASDAI score ≥4) on day of study visit
  • Stable on treatment \[defined as (1) no major change to therapy (change in treatment type) in the preceding 3 months AND (2) no minor change in therapy (adjustment of treatment dosage) in the preceding 1 month\]
  • Age ≥ 16 years
  • Willing and able to give informed written consent.
  • Exclusion. Participants will have NONE of the following:
  • Pregnancy or breastfeeding
  • Prior diagnosis of IBD
  • Recipient of chemotherapy/immunotherapy/radiotherapy in prior 3 months
  • Recent systemic antibiotic use (within last 1 month)
  • Current eating disorder
  • Food allergy incompatible with diet (e.g. cow's milk allergy)
  • Following a vegan diet
  • Major surgery in prior 3 months or planned in forthcoming 3 months.
  • Unable or unwilling to give informed consent
  • Unable or unwilling to try the PEN diet.
  • Eligibility Criteria for Healthy Volunteer Participants
  • Age ≥ 16 years
  • Current student and/or staff member at the University of Glasgow
  • Willing and able to give informed written consent
  • Exclusion. Participants will have NONE of the following:
  • Pregnancy or breastfeeding
  • Prior diagnosis of an immune-mediated inflammatory condition
  • Recipient of chemotherapy/immunotherapy/radiotherapy in prior 3 months
  • Recent systemic antibiotic use (within last 1 month)
  • Current eating disorder
  • Food allergy incompatible with diet (e.g. cow's milk allergy)
  • Following a vegan diet
  • Major surgery in prior 3 months or planned in forthcoming 3 months.
  • Unable or unwilling to give informed consent
  • Unable or unwilling to try the PEN diet.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTPartial enteral nutrition

70% caloric intake from enteral nutrition formula and 30% caloric intake from a limited range of solid foods


Locations(2)

NHS Greater Glasgow and Clyde

Glasgow, United Kingdom

University of Glasgow

Glasgow, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06460805


Related Trials